These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17806133)

  • 1. Fitting observed and theoretical choices - women's choices about prenatal diagnosis of Down syndrome.
    Seror V
    Health Econ; 2008 May; 17(5):557-77. PubMed ID: 17806133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff?
    Grobman WA; Dooley SL; Welshman EE; Pergament E; Calhoun EA
    Prenat Diagn; 2002 Dec; 22(13):1195-200. PubMed ID: 12478632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women.
    Caughey AB; Washington AE; Kuppermann M
    Am J Obstet Gynecol; 2008 Mar; 198(3):333.e1-8. PubMed ID: 18177830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage.
    Chan YM; Leung TN; Leung TY; Fung TY; Chan LW; Lau TK
    Prenat Diagn; 2006 Sep; 26(9):819-24. PubMed ID: 16832829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome.
    Reid B; Sinclair M; Barr O; Dobbs F; Crealey G
    Soc Sci Med; 2009 Dec; 69(11):1561-73. PubMed ID: 19783085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
    Brajenović-Milić B; Babić I; Ristić S; Vraneković J; Brumini G; Kapović M
    Womens Health Issues; 2008; 18(2):79-84. PubMed ID: 18180167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic differences in determinants of participation and non-participation in prenatal screening for Down syndrome: a theoretical framework.
    Fransen MP; Essink-Bot ML; Oenema A; Mackenbach JP; Steegers EA; Wildschut HI
    Prenat Diagn; 2007 Oct; 27(10):938-50. PubMed ID: 17597492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of decision analysis to evaluate patients' choices of diagnostic prenatal test.
    Verp MS; Heckerling PS
    Am J Med Genet; 1995 Sep; 58(4):337-44. PubMed ID: 8533842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The choice of detecting Down syndrome: does money matter?
    Garrouste C; Le J; Maurin E
    Health Econ; 2011 Sep; 20(9):1073-89. PubMed ID: 21671303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive validity of prospect theory versus expected utility in health utility measurement.
    Abellan-Perpiñan JM; Bleichrodt H; Pinto-Prades JL
    J Health Econ; 2009 Dec; 28(6):1039-47. PubMed ID: 19833400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening.
    Seror V; Ville Y
    Prenat Diagn; 2009 Feb; 29(2):120-8. PubMed ID: 19123253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do women know that prenatal testing detects fetuses with Down syndrome?
    Jaques AM; Halliday JL; Bell RJ
    J Obstet Gynaecol; 2004 Sep; 24(6):647-51. PubMed ID: 16147604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding pregnant women's decision making concerning prenatal screening.
    van den Berg M; Timmermans DR; Knol DL; van Eijk JT; de Smit DJ; van Vugt JM; van der Wal G
    Health Psychol; 2008 Jul; 27(4):430-7. PubMed ID: 18643000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's attitudes to the successive decisions possibly involved in prenatal screening for Down syndrome: how consistent with their actual decisions?
    Seror V; Ville Y
    Prenat Diagn; 2010 Nov; 30(11):1086-93. PubMed ID: 20872424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting Down syndrome screening results: women's understanding of risk.
    Nagle C; Hodges R; Wolfe R; Wallace EM
    Prenat Diagn; 2009 Mar; 29(3):234-9. PubMed ID: 19177342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result.
    Kobelka C; Mattman A; Langlois S
    Prenat Diagn; 2009 May; 29(5):514-9. PubMed ID: 19242922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amniocentesis decision: ten years of decision analytic experience.
    Pauker SP; Pauker SG
    Birth Defects Orig Artic Ser; 1987; 23(2):151-69. PubMed ID: 3593909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can we improve the content and quality of information delivered prior to amniocentesis?].
    Malkiel A; Granat M; Sagi M; Brezis M
    Harefuah; 2008 Jan; 147(1):16-20, 96, 95. PubMed ID: 18300617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term trends for socio-economic differences in prenatal diagnosis of Down syndrome: diffusion of services or persistence of disparities?
    Khoshnood B; De Vigan C; Blondel B; Vodovar V; Cadio E; Goffinet F
    BJOG; 2008 Aug; 115(9):1087-95. PubMed ID: 18518869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of prenatal diagnosis and termination of pregnancies for the prevention of Down syndrome in Israel.
    Zlotogora J; Haklai Z; Leventhal A
    Isr Med Assoc J; 2007 Aug; 9(8):600-2. PubMed ID: 17877067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.